US Bancorp
SLRN

US Bancorp’s ACELYRIN SLRN Stock Holding History

US Bancorp’s Portfolio SLRN Stock Details SLRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-16,854
Closed -$83.1K – 4255
2024
Q3 		$83.1K Buy
16,854
+7,336
+77% +$37.9K ﹤0.01% 2487
2024
Q2 		$42K Buy
9,518
+4,241
+80% +$19.9K ﹤0.01% 2761
2024
Q1 		$35.6K Buy
+5,277
New +$40.1K ﹤0.01% 2859
2023
Q4 		– Sell
-32
Closed -$325 – 4139
2023
Q3 		$325 Sell
32
-154
-83% -$3.27K ﹤0.01% 3890
2023
Q2 		$3.89K Buy
+186
New +$3.8K ﹤0.01% 3548

Other funds holding SLRN

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
ACMC
AyurMaya Capital Management Company Portsmouth, New Hampshire $148M AUM 24.4% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
TCM
Tybourne Capital Management Hong Kong $30.9M AUM 20.1% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return

US Bancorp's SLRN Position: Q4 2024 in Review

US Bancorp sold out of ACELYRIN (SLRN) in Q4 2024, closing a stake of 16,854 shares — an estimated $83.1K sold.

US Bancorp first reported a position in SLRN in Q2 2023 and held it in 5 quarters. The position peaked at $83.1K in Q3 2024. 125 funds tracked by Wall St. Rank hold SLRN as of Q4 2024.

  • US Bancorp reported no remaining ACELYRIN position as of Q4 2024 after selling out during the quarter.
  • US Bancorp sold 16,854 ACELYRIN shares in Q4 2024, an estimated $83.1K.
  • US Bancorp first reported a position in ACELYRIN in Q2 2023 and held it in 5 quarters.
  • US Bancorp's ACELYRIN position peaked at $83.1K in Q3 2024.
  • 125 funds tracked by Wall St. Rank held ACELYRIN as of Q4 2024.

Based on US Bancorp's 13F filing for Q4 2024, filed 5 Feb 2025.